OH2 Injection in Melanoma

NCT05868707 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
340
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Binhui Biopharmaceutical Co., Ltd.